Ardena is the new brand name of four companies that merged on their path to establish a leading contract development and manufacturing organization for the pharmaceutical industry. The Ardena Group is organized among several business units that offer complementary expert services.
Ardena is your one source partner to help you navigate the drug development process from molecule to clinic.
We offer an integrated, flexible service encompassing drug substance production, dosage form manufacture, clinical logistics, bioanalysis and dossier development.
We are also at the leading edge of nanomedicine development. Our precision particle engineering and characterisation technologies are the key to accessing this fast evolving, competitive market.
We have a European development and manufacturing base, but a global reach. Our vast experience and expertise in all stages of drug development, combined with our dossier-centric approach, help customers progress life-saving medicines to patients quickly and reliably.
Netherlands based Crystallics is the first company that joined Ardena in executing its vertical integration strategy. Crystallics is specialized in the identification, characterization and selection of the physical forms of drug substances. The company is a pioneer in the field of solid-state research and developed unique and proprietary technologies.